K-CAB Surge and Vaccine Distribution Put HK inno.N on the Verge of ₩1 Trillion in Annual Sales
HK inno.N is closing in on its first-ever annual sales of ₩1 trillion. According to financial data provider…
inno.N
2 개의 기사가 있습니다.
HK inno.N's K-CAB Receives Approval in Malaysia
HK inno.N's novel drug for gastroesophageal reflux disease (GERD), K-CAB, has received marketing approval in Malaysia. HK inno.N…